Gala vs Remedy Meds
Remedy Meds has an open FDA warning letter dated September 9, 2025. Gala has none. On compounded tirzepatide injection, Gala costs $2,640 less a year at standing rates: $179 a month against $399 a month at Remedy Meds. It is one of two products the two sell at comparable terms.
To see where both sit among the other sellers, read our best weight-loss injection providers board.
The record
Gala / Remedy Meds
Featured pick (affiliate partner)
Gala
8.5/10
Remedy Meds
5.6/10
Gala is our featured pick on this page because it is an affiliate partner: we are paid if you sign up through our link. Remedy Meds pays us nothing. The scores are computed the same way for both and are shown as computed (Gala 8.5, Remedy Meds 5.6). How we are paid
What the record shows
- 01
Remedy Meds has an open FDA warning letter dated September 9, 2025. Gala has none.
- 02
Neither names the pharmacy that compounds its medication.
- 03
On compounded tirzepatide injection, Gala costs $2,640 less a year at standing rates: $179 a month against $399 a month at Remedy Meds. It is one of two products the two sell at comparable terms.
- 04
Only Gala lists a price for brand-name semaglutide pen.
- 05
Gala covers one state Remedy Meds does not.
Prices and terms, product by product
A price is set against the other side only for the same product, and only when both are standing monthly or 4-week rates. Those pairs are compared by yearly cost.
Gala
Remedy Meds
$179/moLower
$2,148 a year
$299/mo
$3,588 a year
$179/moLower
$2,148 a year
$399/mo
$4,788 a year
$1,299/mo
$15,588 a year
Read off each seller’s own pages. Gala: October 17, 2026. Remedy Meds: October 30, 2026. Every plan and dose we hold is on the full review.
The case for each
The case for Gala
8.5/10- No FDA warning letter on record
- $1,440 a year less on compounded semaglutide injection
- $2,640 a year less on compounded tirzepatide injection
- Sells brand-name semaglutide pen, which Remedy Meds does not price
- Names no compounding pharmacy
The case for Remedy Meds
5.6/10The record gives Remedy Meds no edge on this pair.
- Open FDA warning letter, September 9, 2025
- Names no compounding pharmacy
Scores
Gala 8.5 · Remedy Meds 5.6 out of 10. Six weighted parts.
Value25%
Effectiveness25%
User Experience15%
Trust & Safety15%
Accessibility10%
Support10%
The score is the same formula for every seller. Payment does not enter it. Method
Gala vs Remedy Meds: questions
Other sellers we are paid by
Affiliate partners outside this pair. Each has its own record and review, scored the same way.
- Embody9.3
From $79/mo
Visit site From $179/mo
Visit site- Collective9.1
From $59/mo
Visit site
Sellers closest to these two
- Gala vs Noom
- Gala vs Luvo Health
- Gala vs DudeMeds
- Gala vs Hers
- Remedy Meds vs TrimRx
- Remedy Meds vs Willow
Matched on molecule, form and price. Every pair we list · The register
Brand names on this page are registered marks. Novo Nordisk holds Wegovy®, Ozempic® and Rybelsus®; Eli Lilly holds Zepbound®, Mounjaro® and Foundayo®. Neither company has any tie to GLP Watchdog. Trademarks